JOANNE PIAGGIO: Open Payments
NPI 1194372086 · POINT PLEASANT BORO, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,635 in 110 payments from 15 companies in 2025. Trend: 2023 $326 · 2024 $845 · 2025 $1,635
Food & beverage: $1,635
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 20 | $289 |
| ABBVIE INC. | 18 | $235 |
| Tris Pharma Inc | 12 | $183 |
| Lundbeck LLC | 12 | $178 |
| Axsome Therapeutics, Inc. | 11 | $175 |
| Bausch Health US, LLC | 11 | $146 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $101 |
| Alkermes, Inc. | 5 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $70 |
| Vanda Pharmaceuticals Inc. | 3 | $47 |
Products named: REXULTI, VRAYLAR, Auvelity, Dyanavel XR, WELLBUTRIN, TRINTELLIX, CAPLYTA, ARISTADA.
Industry payments across NJ — which companies pay providers there.
